<DOC>
	<DOC>NCT01051336</DOC>
	<brief_summary>The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.</brief_summary>
	<brief_title>Safety and Tolerability Study of the Taris Placebo System</brief_title>
	<detailed_description />
	<criteria>Healthy female volunteers, 18 to 55 years of age Body weight &gt;100 lbs and BMI (body mass index) within the range 1830 kg/m2 A score of less than 11 on the pelvic pain/urgencyfrequency scale (PUF) Presence of any bladder or urethra anatomical feature that, in the opinion of the investigator, might prevent the safe placement, indwelling use, or removal of the TARIS placebo system History of significant urogenital surgery (any type of bladder suspension, prolapse repair, incontinence procedure, or vaginal hysterectomy) History of kidney stone formation Chronic or recurring bacterial or viral infections of the urogenital system</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>TARIS Placebo</keyword>
	<keyword>Bladder</keyword>
	<keyword>Interstitial Cystitis</keyword>
	<keyword>Normal Healthy Volunteers</keyword>
</DOC>